Carcinoembryonic Antigen (CEA) Market Is Expected To Reach USD 2.69 Billion By 2032.
Market Overview: The global market size for Carcinoembryonic Antigen (CEA) was USD 1.59 Billion in 2022 and is projected to reach USD 2.69 Billion by 2032, exhibiting a revenue Compound Annual Growth Rate (CAGR) of 6% throughout the forecast period. The primary drivers of market growth include the increasing incidence of cancer, with CEA tests…
Read More “Carcinoembryonic Antigen (CEA) Market Is Expected To Reach USD 2.69 Billion By 2032.” »